Biotech

Governor Jim Doyle proposed a joint public-private initiative that would allocate $80 million in state funds and leverage an additional $370 million in private investment for the development of renewable energy programs in Wisconsin. The initiative includes the nation's first cellulosic ethanol plant, and a...

State politicians have stem cells on the brain when it comes to supporting Milwaukee's academic research centers, but Inside Wisconsin columnist Tom Still argues they should instead focus on making sure those centers collaborate to reach their full potential and advance the region's tech economy....

Mirus Bio Corp., a biopharmaceutical firm operating from the University Research Park, has developed a new method to use its DNA and RNA injection technology to target gene activity. The new technique could make analyzing gene function in vivo more efficient and affordable for researchers,...

In a new study by the Milken Institute, the University of Wisconsin System was ranked 9th in number and quality of biotechnology patents, but well behind several Big Ten campuses in its ability to transfer the intellectual property into commercial uses....

The International Economic Development Council (IEDC) has recognized the Center for Advanced Technology and Innovation (CATI) for its technology-based economic development programs. CATI, based in Racine, has developed a technology transfer model to help entrepreneurs grow their business. ...

Platypus Technologies, LLC, a life sciences and nanotechnology company operating in suburban Madison, has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant. The award, which is worth $450,000, will be used to develop new life science research tools....

Throwing down the gauntlet in the heat of the election season, Wisconsin Gov. Jim Doyle is challenging the Wisconsin Legislature to approve $2.5 in spending for the Biomedial Technology Alliance. Additional funding for the alliance, a group of southeastern Wisconsin colleges and universities interested in...

Tetsuro Wakatsuki and Ayla Annac founded InvivoSciences to provide a way to test drug candidates on living tissue - without the need for inefficient animal testing. The company now is gearing up to send its screening system into a $6 billion market....